Pain relief, no opioids: Biotech gets NIH grant for new drug

Months after launching publicly with $26 million in venture funding, biotech startup 1910 Genetics has inked its first government contract. The startup will explore non-opioid pain relief with the help of a $550,000 grant through the National Institutes of Health's Small Business Technology Transfer program. The pain management program is Cambridge-based 1910 Genetics' first disclosed target. The grant requires the company to come up with a lead drug candidate by next December, with the option to…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news